Neural Regeneration Research ›› 2019, Vol. 14 ›› Issue (7): 1138-1143.doi: 10.4103/1673-5374.251190

Previous Articles     Next Articles

Potential therapeutic molecular targets for bloodbrain barrier disruption after subarachnoid hemorrhage

Hideki Kanamaru, Hidenori Suzuki   

  1. Department of Neurosurgery, Mie University Graduate School of Medicine, Tsu, Japan
  • Online:2019-07-15 Published:2019-07-15
  • Contact: Hidenori Suzuki, MD, PhD, suzuki02@clin.medic.mie-u.ac.jp
  • Supported by:

    This work was supported by a grant-in-aid for Scientific Research from Japan Society for the Promotion of Science (grant number: 17K10825) to HS.

Abstract:

Aneurysmal subarachnoid hemorrhage remains serious hemorrhagic stroke with high morbidities and mortalities. Aneurysm rupture causes arterial bleeding-induced mechanical brain tissue injuries and elevated intracranial pressure, followed by global cerebral ischemia. Post-subarachnoid hemorrhage ischemia, tissue injuries as well as extravasated blood components and the breakdown products activate microglia, astrocytes and Toll-like receptor 4, and disrupt blood-brain barrier associated with the induction of many inflammatory and other cascades. Once blood-brain barrier is disrupted, brain tissues are directly exposed to harmful blood contents and immune cells, which aggravate brain injuries furthermore. Blood-brain barrier disruption after subarachnoid hemorrhage may be developed by a variety of mechanisms including endothelial cell apoptosis and disruption of tight junction proteins. Many molecules and pathways have been reported to disrupt the blood-brain barrier after subarachnoid hemorrhage, but the exact mechanisms remain unclear. Multiple independent and/or interconnected signaling pathways may be involved in blood-brain barrier disruption after subarachnoid hemorrhage. This review provides recent understandings of the mechanisms and the potential therapeutic targets of blood-brain barrier disruption after subarachnoid hemorrhage.

Key words: blood-brain barrier, early brain injury, endothelial cell, subarachnoid hemorrhage, tight junction, inflammation, matricellular protein, Toll-like receptor 4